Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,836 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06994754Recruiting
Expanding the upper jaw with clear aligners in cleft lip and palate patients
This trial tests whether clear aligners can safely widen the upper jaw in children with cleft lip and palate who still have some baby teeth. It may be an option for those needing jaw expansion without braces.
Cairo, SelectAges 6–12 - NCT06994845RecruitingPhase 3
Testing iptacopan for children with IgA nephropathy
This study tests a new medicine called iptacopan to see if it helps children with IgA nephropathy (a kidney disease). Kids who join will receive the study treatment and be monitored for safety and effectiveness.
Aurora, ColoradoAges 2–18 - NCT06995131Recruiting
Eye fluid study in diabetes and cataract patients
This study looks at two proteins (DEL-1 and IL-17) in the fluid inside the eye of people with diabetes who are having cataract surgery. It aims to understand how these proteins might be linked to eye health in diabetes.
Uşak, UşakAges 50–80 - NCT06995248Recruiting
Laughter yoga for cancer patients and caregivers
This trial explores whether laughter yoga can help reduce pain and fatigue and improve overall well-being for people with cancer and the people who care for them.
AnkaraAges 18–65 - NCT06995339RecruitingPhase 2
Metformin vs. Febuxostat for gout in obesity without diabetes
This study compares two medicines—metformin (usually for diabetes) and febuxostat (for gout)—in people who have both gout and obesity but not diabetes. The goal is to see which works better for controlling gout and related health markers.
Damietta, New DamiettaAges 18–65 - NCT06995508RecruitingPhase 2
Olanzapine for appetite loss in head and neck cancer patients
This trial tests if the drug olanzapine can help improve appetite in people with head and neck cancer who are getting chemotherapy and radiation. It aims to prevent or reduce weight loss during treatment.
Buffalo, New YorkAges 18 years+ - NCT06995742Recruiting
Effect of a vital sign device on staff workload
This study tests whether using a special device (ANNE One-Wellue) to monitor vital signs reduces how often hospital staff need to take measurements manually. It is for patients staying on a specific hospital unit.
Chicago, IllinoisAges 18 years+ - NCT06995833Recruiting
Durvalumab with or without Olaparib for endometrial cancer
This trial collects safety information on the standard use of Durvalumab (with or without Olaparib) in people with endometrial cancer in Korea. It helps doctors confirm the real-world effects of these approved treatments.
SeoulAges Any age - NCT06995924Recruiting
Improving follow-up care for colorectal cancer survivors
This study tests whether a navigator and online education can help colorectal cancer survivors get the recommended follow-up tests after surgery. If you've had surgery for stage I-III colorectal cancer in the last 3 months, this program may support you in staying on track with your surveillance.
Seattle, WashingtonAges 18 years+ - NCT06996353Recruiting
A study of laser eye correction for nearsightedness
This study is collecting health information from people who have undergone a specific laser eye correction procedure (PTK-PRK) for nearsightedness with or without astigmatism. It aims to understand how well the treatment works and how safe it is.
Chandigarh, Punjab HaryanaAges Any age - NCT06996574Recruiting
Comparing an all-in-one procedure with at-home screening for chronic pain
This trial tests if a single, all-in-one procedure works as well as the usual two-step process (screening at home first) for people with long-term nerve pain. It looks at how well pain is controlled and whether the simpler approach saves money.
AmsterdamAges 18 years+ - NCT06996951RecruitingPhase 3
Sinus treatments in cystic fibrosis with modern modulator therapy
This study looks at how different sinus treatments affect people with cystic fibrosis who are taking modern modulator therapy. It aims to understand which rinses work best for chronic sinus problems.
Indianapolis, IndianaAges 18 years+ - NCT06997055Recruiting
Study of Steqeyma® biosimilar in Crohn's and psoriasis
This study follows people with Crohn's disease or plaque psoriasis who are switching from the reference Ustekinumab to a biosimilar (Steqeyma®). It aims to see how well the biosimilar works in real-world settings.
AmiensAges 18 years+ - NCT06998108RecruitingPhase 3
A new drug with fulvestrant for HR+/HER2- advanced breast cancer
This trial tests a new investigational drug called BEBT-209 combined with fulvestrant (a hormone therapy) versus placebo with fulvestrant for people with a type of breast cancer that is hormone receptor-positive and HER2-negative. It is for those whose cancer has worsened after previous hormone therapy and has spread locally or to other parts of the body.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06998628RecruitingPhase 2
Pentoxifylline for rheumatoid arthritis inflammation
This study tests if pentoxifylline, a medicine typically used for circulation, can help reduce joint inflammation in people with rheumatoid arthritis who still have active symptoms despite taking standard DMARDs.
Damietta, Damietta GovernorateAges 18–70 - NCT06998745Recruiting
Anticoagulant therapy support for colorectal cancer patients with blood clots
This trial tests whether a medication therapy management (MTM) model helps make blood thinner treatment safer and more effective for colorectal cancer patients who have also developed dangerous blood clots. It aims to improve how well patients stick to their medication and reduce complications.
Guangzhou, GuangdongAges 18–100 - NCT06998888Recruiting
Remote monitoring for cancer patients on oral medications
This study tests whether a smartphone app (Caaring®) can help monitor cancer patients who take oral medications. If you are on an oral cancer treatment and comfortable using a smartphone, this trial may help you stay connected with your care team and manage side effects from home.
Boadilla del Monte, MadridAges 18 years+ - NCT06999031RecruitingEarly Phase 1
CG-105-12 for relapsed/refractory multiple myeloma
This trial tests a new CAR-T cell therapy called CG-105-12 for people with multiple myeloma that has come back or stopped responding to other treatments. It aims to see if this therapy can help when at least 3 prior treatments have failed.
Nanchang, JiangxiAges 18–75 - NCT06999161Recruiting
Tracking Antibiotic Levels in ICU Brain Injury Patients
This study monitors the amount of certain antibiotics in the blood of patients with acute brain injury in the intensive care unit. It aims to make sure the antibiotics are at the right level to fight infection, especially in patients whose kidneys are clearing drugs faster than normal.
NîmesAges 18 years+ - NCT06999187RecruitingPhase 1
Study of DR-0202 for advanced solid tumors after multiple treatments
This trial tests a new drug, DR-0202, for people with certain advanced cancers that have not responded to at least two prior treatments. It may be an option if standard treatments are no longer working.
Denver, ColoradoAges 18 years+ - NCT06999603RecruitingPhase 2
Inhaled study drug for virus infections on ventilators
This study tests an inhaled study drug (SNG001) for adults on a breathing machine in the ICU due to a viral lung infection. The goal is to see if the drug can help patients recover faster.
Sacramento, CaliforniaAges 18 years+ - NCT06999616Recruiting
Physical activity program for cancer patients in day clinic
This trial tests a nurse-led physical activity program for cancer patients receiving treatment at an outpatient clinic. It aims to help you stay active during your cancer care.
MünsterlingenAges 18 years+ - NCT06999785Recruiting
Oxygen therapy safety study for radiation treatment side effects
This trial tests whether extra oxygen sessions (hyperbaric oxygen therapy) cause DNA damage in people who have had radiation for cancer. It looks at patients with side effects like bladder or skin issues from past radiation.
AngersAges 18 years+ - NCT06999954Recruiting
Global survey for Shwachman-Diamond syndrome and related conditions
This trial is a global survey and registry for people with Shwachman-Diamond Syndrome and related inherited blood disorders. It aims to connect patients, families, and researchers to better understand these conditions and improve care.
Woburn, MassachusettsAges Any age
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,836 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.